Please Wait...

  • +91 22 2783 1455

  • Product background
    TELSANAR (Telmisartan Tablets USP 20mg)

WARNING: CAUTION : PLEASE NOTE :
The content or product detailing is not intended to replace advice from your prescribing doctor or healthcare professional. Lavina Pharma is not responsible for such actions by consumers. For any further information about the product please contact +91 22 2783 1455 and we can provide you the details.

TELSANAR tablet is used for treatment of essential hypertension in adults. Reduction of 

Cardiovascular morbidity in adults with manifest atherothrombotic cardiovascular disease and 

Type 2 diabetes mellitus with documented target organ damage.  



TELSANAR tablet is used for treatment of essential hypertension in adults. Reduction of 

Cardiovascular morbidity in adults with manifest atherothrombotic cardiovascular disease and 

Type 2 diabetes mellitus with documented target organ damage.  





COMPOSITION

Each film coated tablet contains:

Telmisartan USP …….20 mg

Excipients……………...  q.s

Colour: Titanium Dioxide


         Oral

DOSAGE

As directed by the physician.


SIDE EFFECT

 Anaemia

 Hypersensitivity, Abdominal pain

 Diarrhoea, flatulence, vomiting





PRECAUTION

When pregnancy is diagnosed, treatment with angiotensin II receptor antagonists should be

stopped immediately, and, if appropriate, alternative therapy should be started.

Hepatic impairment: Telmisartan is not to be given to patients with cholestasis, biliary

obstructive disorders or severe hepatic impairment since telmisartan is mostly eliminated with

the bile.

Renovascular hypertension: There is an increased risk of severe hypotension and renal

insufficiency when patients with bilateral renal artery stenosis or stenosis of the artery to a single

functioning kidney are treated with medicinal products that affect the renin-angiotensin-

aldosterone system.

Diabetic patients treated with insulin or antidiabetics: In these patients hypoglycaemia may

occur under telmisartan treatment. Therefore, in these patients an appropriate blood glucose

monitoring should be considered; a dose adjustment of insulin or antidiabetics may be   required,

when indicated.

 




PRESENTATION

10 X 10 Tablets.